CN100367940C - 妇宁康薄膜衣片的制备方法 - Google Patents
妇宁康薄膜衣片的制备方法 Download PDFInfo
- Publication number
- CN100367940C CN100367940C CNB2006100203482A CN200610020348A CN100367940C CN 100367940 C CN100367940 C CN 100367940C CN B2006100203482 A CNB2006100203482 A CN B2006100203482A CN 200610020348 A CN200610020348 A CN 200610020348A CN 100367940 C CN100367940 C CN 100367940C
- Authority
- CN
- China
- Prior art keywords
- volatile oil
- hours
- coating
- radix
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000011248 coating agent Substances 0.000 title claims abstract description 36
- 238000000576 coating method Methods 0.000 title claims abstract description 36
- 238000000034 method Methods 0.000 title claims description 11
- 239000000341 volatile oil Substances 0.000 claims abstract description 50
- 239000003814 drug Substances 0.000 claims abstract description 35
- 238000002360 preparation method Methods 0.000 claims abstract description 23
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 19
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 19
- 239000007888 film coating Substances 0.000 claims abstract description 19
- 238000009501 film coating Methods 0.000 claims abstract description 19
- 235000008434 ginseng Nutrition 0.000 claims abstract description 19
- 229940079593 drug Drugs 0.000 claims abstract description 10
- 238000000605 extraction Methods 0.000 claims abstract description 8
- -1 granulation Substances 0.000 claims abstract description 8
- 239000002994 raw material Substances 0.000 claims abstract description 3
- 238000005469 granulation Methods 0.000 claims abstract 2
- 230000003179 granulation Effects 0.000 claims abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 35
- 239000000843 powder Substances 0.000 claims description 27
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 23
- 239000000284 extract Substances 0.000 claims description 20
- 241000208340 Araliaceae Species 0.000 claims description 18
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 18
- 239000000047 product Substances 0.000 claims description 17
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 15
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 12
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 12
- 239000007788 liquid Substances 0.000 claims description 12
- 239000000463 material Substances 0.000 claims description 12
- 238000001035 drying Methods 0.000 claims description 11
- 239000000706 filtrate Substances 0.000 claims description 11
- 229920000858 Cyclodextrin Polymers 0.000 claims description 10
- 239000007864 aqueous solution Substances 0.000 claims description 10
- 238000002156 mixing Methods 0.000 claims description 10
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims description 10
- 238000005507 spraying Methods 0.000 claims description 10
- 238000003756 stirring Methods 0.000 claims description 10
- 239000008187 granular material Substances 0.000 claims description 9
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Inorganic materials [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 claims description 7
- NDLPOXTZKUMGOV-UHFFFAOYSA-N oxo(oxoferriooxy)iron hydrate Chemical compound O.O=[Fe]O[Fe]=O NDLPOXTZKUMGOV-UHFFFAOYSA-N 0.000 claims description 7
- 210000000582 semen Anatomy 0.000 claims description 7
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 6
- 238000005453 pelletization Methods 0.000 claims description 6
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 claims description 5
- 239000000084 colloidal system Substances 0.000 claims description 5
- 239000000428 dust Substances 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- 238000007602 hot air drying Methods 0.000 claims description 5
- 238000004321 preservation Methods 0.000 claims description 5
- 229920002565 Polyethylene Glycol 400 Polymers 0.000 claims description 4
- JLFNLZLINWHATN-UHFFFAOYSA-N pentaethylene glycol Chemical compound OCCOCCOCCOCCOCCO JLFNLZLINWHATN-UHFFFAOYSA-N 0.000 claims description 4
- 238000005303 weighing Methods 0.000 claims description 4
- 239000004925 Acrylic resin Substances 0.000 claims description 3
- 239000012141 concentrate Substances 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 abstract description 12
- 239000000203 mixture Substances 0.000 abstract description 5
- 230000002349 favourable effect Effects 0.000 abstract 2
- 244000001632 Acorus gramineus Species 0.000 abstract 1
- 235000013073 Acorus gramineus Nutrition 0.000 abstract 1
- 241000605445 Anemarrhena asphodeloides Species 0.000 abstract 1
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 241000196324 Embryophyta Species 0.000 abstract 1
- 244000241838 Lycium barbarum Species 0.000 abstract 1
- 235000015459 Lycium barbarum Nutrition 0.000 abstract 1
- 235000015468 Lycium chinense Nutrition 0.000 abstract 1
- 241000736199 Paeonia Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 240000005001 Paeonia suffruticosa Species 0.000 abstract 1
- 235000003889 Paeonia suffruticosa Nutrition 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 241000972673 Phellodendron amurense Species 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 239000006286 aqueous extract Substances 0.000 abstract 1
- 229940126678 chinese medicines Drugs 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 230000007613 environmental effect Effects 0.000 abstract 1
- 238000010298 pulverizing process Methods 0.000 abstract 1
- 238000003908 quality control method Methods 0.000 abstract 1
- 210000003734 kidney Anatomy 0.000 description 15
- 239000003826 tablet Substances 0.000 description 12
- 208000011580 syndromic disease Diseases 0.000 description 9
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 241000238370 Sepia Species 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000007941 film coated tablet Substances 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 239000005556 hormone Substances 0.000 description 4
- 229940088597 hormone Drugs 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 230000009245 menopause Effects 0.000 description 4
- 230000008093 supporting effect Effects 0.000 description 4
- 241000605447 Anemarrhena Species 0.000 description 3
- YKRGDOXKVOZESV-WRJNSLSBSA-N Paeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-WRJNSLSBSA-N 0.000 description 3
- 241000208966 Polygala Species 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 230000001914 calming effect Effects 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 210000005036 nerve Anatomy 0.000 description 3
- 238000005457 optimization Methods 0.000 description 3
- 230000003014 reinforcing effect Effects 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 206010010356 Congenital anomaly Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000035558 fertility Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 208000037920 primary disease Diseases 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 208000010392 Bone Fractures Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000006332 Choriocarcinoma Diseases 0.000 description 1
- 241001269238 Data Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 206010014733 Endometrial cancer Diseases 0.000 description 1
- 206010014759 Endometrial neoplasm Diseases 0.000 description 1
- 206010017076 Fracture Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 206010034568 Peripheral coldness Diseases 0.000 description 1
- 208000002500 Primary Ovarian Insufficiency Diseases 0.000 description 1
- 244000296102 Selinum monnieri Species 0.000 description 1
- 235000019084 Selinum monnieri Nutrition 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 206010046914 Vaginal infection Diseases 0.000 description 1
- 201000008100 Vaginitis Diseases 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000000881 depressing effect Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 229940126534 drug product Drugs 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 201000003914 endometrial carcinoma Diseases 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 238000002657 hormone replacement therapy Methods 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000009247 menarche Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 206010029446 nocturia Diseases 0.000 description 1
- 230000001777 nootropic effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 230000027758 ovulation cycle Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- YKRGDOXKVOZESV-UHFFFAOYSA-N paeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(CO)O5)O)CC3(O)OC1C24COC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-UHFFFAOYSA-N 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 238000011020 pilot scale process Methods 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 206010036601 premature menopause Diseases 0.000 description 1
- 208000017942 premature ovarian failure 1 Diseases 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 238000009495 sugar coating Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 208000000143 urethritis Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
Images
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
批号 | 040401 | 040402 | 040403 |
投料量(kg)药粉重(kg)辅料(kg)应得片数(片)实得片数(片)成品收率(%) | 9.732.520.510000895089.5 | 9.732.480.510000886088.6 | 9.732.550.510000894089.4 |
批号 | 040401 | 040402 | 040403 |
性状鉴别重量差异(%)崩解时限(min)微生物限度芍药苷含量(mg/片) | 本品为薄膜衣片,除去薄膜衣后显棕褐色;味苦符合规定符合规定18符合规定0.88 | 本品为薄膜衣片,除去薄膜衣后显棕褐色;味苦符合规定符合规定19符合规定0.79 | 本品为薄膜衣片,除去薄膜衣后显棕褐色;味苦符合规定符合规定19符合规定0.81 |
比较指标 | 妇宁康薄膜衣片 | 上市妇宁康片 |
服用量(每次) | 相同 | 相同 |
崩解时限(min) | 18 | 19 |
性状 | 本品为薄膜衣片,除去薄膜衣后显棕褐色;味苦。 | 本品为糖衣片,除去糖衣后显棕褐色;味苦。 |
鉴别 | 薄层定性鉴别枸杞子、芍药、黄柏、远志、知母、蛇床子 | 显微鉴别薄层定性鉴别枸杞子、芍药苷、黄柏 |
含量控制指标 | HPLC测定芍药苷 | 无 |
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100203482A CN100367940C (zh) | 2006-02-24 | 2006-02-24 | 妇宁康薄膜衣片的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100203482A CN100367940C (zh) | 2006-02-24 | 2006-02-24 | 妇宁康薄膜衣片的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1850234A CN1850234A (zh) | 2006-10-25 |
CN100367940C true CN100367940C (zh) | 2008-02-13 |
Family
ID=37131746
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2006100203482A Expired - Fee Related CN100367940C (zh) | 2006-02-24 | 2006-02-24 | 妇宁康薄膜衣片的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100367940C (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101708255B (zh) * | 2009-10-22 | 2012-05-23 | 周威 | 一种治疗抑郁症的中药组合物 |
CN102526385B (zh) * | 2012-01-17 | 2013-07-24 | 丁敏 | 一种治疗更年期综合征的药剂 |
CN104606477A (zh) * | 2015-01-28 | 2015-05-13 | 广西日田药业集团有限责任公司 | 清火栀麦片薄膜衣片及其制备方法 |
CN104645245B (zh) * | 2015-03-15 | 2017-11-10 | 陈明友 | 一种用于女性更年期抑郁药物制剂的制备方法 |
CN104645246B (zh) * | 2015-03-15 | 2017-12-01 | 倪瑞云 | 一种用于女性更年期抑郁的药物制剂 |
CN114223864A (zh) * | 2021-12-30 | 2022-03-25 | 山东双贝食品有限公司 | 一种水果复合风味的山药制品及其制作方法 |
-
2006
- 2006-02-24 CN CNB2006100203482A patent/CN100367940C/zh not_active Expired - Fee Related
Non-Patent Citations (1)
Title |
---|
《药品标准中药成方制剂》. 卫生部药典委员会,81,卫生部药典委员会. 1998 * |
Also Published As
Publication number | Publication date |
---|---|
CN1850234A (zh) | 2006-10-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101513437A (zh) | 一种抗疲劳中药组合物及其制备方法 | |
CN100367940C (zh) | 妇宁康薄膜衣片的制备方法 | |
CN104856968A (zh) | 一种具有消栓通络作用的中药片剂及其制备方法 | |
CN103356801A (zh) | 低温连续提取结合膜分离技术制备八珍颗粒的方法 | |
CN102614281B (zh) | 一种提高缺氧耐受力的中药组合物及其制备方法和应用 | |
CN101406598B (zh) | 治疗糖尿病的中药组合物及其制备方法 | |
CN102824480B (zh) | 一种含藏药滇结香的辅助降血糖组合物及制备方法 | |
CN105362776B (zh) | 一种治疗甲状腺机能亢进症的中药组合物、制备方法及其应用 | |
CN103349707A (zh) | 八珍颗粒的制备方法 | |
CN101628059B (zh) | 一种药物组合物和含有该药物组合物的药物制剂 | |
CN100488544C (zh) | 一种改进的治疗妇女更年期综合症的中药胶囊 | |
CN103285329B (zh) | 一种治疗妇女痛经的药物及其制备方法 | |
CN104984296A (zh) | 一种治疗女性更年期综合症的药物组合物及其制备方法 | |
CN104606628A (zh) | 一种养颜美容、祛黄褐斑的中药组合物 | |
CN101224283A (zh) | 治疗糖尿病的中药组合物及其制备方法 | |
CN104474195A (zh) | 一种治疗白癜风的中药复方制剂及其制备方法 | |
CN104127603A (zh) | 一种降脂片制备工艺 | |
CN103961582B (zh) | 治疗肾炎的中药组合物及其制剂和制备方法 | |
CN104055963B (zh) | 一种减脂中药组合物及制备方法 | |
CN104547022A (zh) | 一种清热润肺和利咽解毒的中药组合物 | |
CN104208579B (zh) | 一种参杞归术药物组合物及其制备方法 | |
CN109331156A (zh) | 一种生发黑发胶囊及其制备方法 | |
CN107875288A (zh) | 具有活血、美容功效的中药组合物及其颗粒剂的制备方法 | |
CN101991760A (zh) | 一种治疗更年期综合症的中成药及其制备方法 | |
CN108938993B (zh) | 一种具有安胎作用的大蜜丸及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: CHENGDU SENKE PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: SHI SHENGHONG Effective date: 20100409 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 610031 NO.10, UNIT 2, BUILDING 3, NO.9, MUDIAN ROAD, QINGYANG DISTRICT, CHENGDU CITY, SICHUAN PROVINCE TO: 610105 NO.145, WAIDONG STREET, XINFAN TOWN, CHENGDU CITY, SICHUAN PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20100409 Address after: 610105, No. 145 East Street, Chengdu City, Sichuan Province Patentee after: CHENGDU SENKE PHARMACEUTICAL CO., LTD. Address before: 610031, No. 2, unit 3, 10, circuit 9, Qingyang District, Chengdu, Sichuan Patentee before: Shi Shenghong |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080213 Termination date: 20200224 |